Symbenda Post-Marketing Surveillance (PMS)

You may be eligible if

• Subjects who are prescribed with Symbenda per approved prescribing information of Symbenda will be enrolled in the study.
• Patients who meet the following criteria will be eligible for inclusion in the study:
• 1. Patients with approved indication for Symbenda in Korea